Journal of Bioanalysis & Biomedicine

Hila Epstein Ph.D. is Vice President of Research and Development at Azura Ophthalmics. With more than 15 years of experience in the pharmaceutical/biotech industry, Hila has served in numerous global R&D management positions. Most recently, she spent three years at Teva Pharmaceuticals Global R&D as Director of New Technologies Entities, leading the Israeli NTE R&D team developing 505b2 products from proof of concept to clinical stage, focusing on oral solid doses and nasal formulations. Hila holds a Ph.D. in Pharmacy from the Hebrew University of Jerusalem and is a pharmacist in training from the Hebrew University of Jerusalem.